Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety and efficacy of K-321 Eye Drops after Descemetorhexis in Fuchs Endothelial Corneal Dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Endothelial Corneal Dystrophy

Drugs mentioned

• K-321 Eye Drops (K-321)

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Fuchs Endothelial Corneal Dystrophy | Phase 3 | Status: COMPLETED